Cytokinetics (CYTK) Insider Trading & Ownership $38.89 +0.88 (+2.32%) As of 02:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$12.54M Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYTK Insider Buying and Selling by Quarter Cytokinetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/14/2025Robert I BlumCEOSell5,000$38.15$190,750.00 7/8/2025Fady Ibraham MalikEVPSell2,000$33.76$67,520.00 6/16/2025Robert I BlumCEOSell5,000$33.80$169,000.00 6/5/2025Andrew CallosEVPSell8,659$32.04$277,434.36 6/5/2025Edward M Md KayeDirectorSell3,636$32.10$116,715.60 6/2/2025Robert I BlumCEOSell5,000$31.22$156,100.00 5/15/2025Muna BhanjiDirectorSell1,454$29.73$43,227.42 5/5/2025Andrew CallosEVPSell4,002$36.68$146,793.36 4/29/2025Robert I BlumCEOSell5,000$40.96$204,800.00 4/22/2025Fady Ibraham MalikEVPSell2,000$38.11$76,220.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/21/2025Wendall WierengaDirectorSell20,000$38.46$769,200.00 4/15/2025John T HendersonDirectorSell3,190$38.66$123,325.40 4/10/2025Robert I BlumCEOSell5,000$36.77$183,850.00 4/7/2025Andrew CallosEVPSell2,886$35.78$103,261.08 4/3/2025Robert Arthur HarringtonDirectorSell450$39.43$17,743.50 3/31/2025Robert I BlumCEOSell15,000$40.75$611,250.00 3/17/2025Andrew CallosEVPSell2,775$44.38$123,154.50 3/17/2025Robert I BlumCEOSell12,648$44.38$561,318.24 3/14/2025Andrew CallosEVPSell100$45.00$4,500.00 3/6/2025Andrew CallosEVPSell3,341$43.27$144,565.07 3/6/2025Robert I BlumCEOSell16,970$43.44$737,176.80 2/18/2025Fady Ibraham MalikEVPSell2,000$45.98$91,960.00 2/4/2025Fady Ibraham MalikEVPSell2,000$48.06$96,120.00 1/21/2025Fady Ibraham MalikEVPSell2,000$45.92$91,840.00 1/7/2025Fady Ibraham MalikEVPSell2,000$49.32$98,640.00 12/16/2024Wendall WierengaDirectorSell742$48.61$36,068.62 12/11/2024John T HendersonDirectorSell1,780$50.42$89,747.60 12/10/2024Fady Ibraham MalikEVPSell7,300$50.64$369,672.00 12/2/2024Robert I BlumCEOSell5,000$50.76$253,800.00 11/26/2024Fady Ibraham MalikEVPSell7,300$50.16$366,168.00 11/18/2024Robert I BlumCEOSell5,000$50.55$252,750.00 11/12/2024Fady Ibraham MalikEVPSell6,342$58.48$370,880.16 11/1/2024Robert I BlumCEOSell5,000$51.63$258,150.00 10/30/2024Fady Ibraham MalikEVPSell7,300$51.91$378,943.00 10/28/2024Wendall WierengaDirectorSell4,452$52.25$232,617.00 10/15/2024Fady Ibraham MalikEVPSell7,300$54.19$395,587.00 10/9/2024Robert I BlumCEOSell5,000$55.61$278,050.00 10/1/2024Fady Ibraham MalikEVPSell7,300$52.10$380,330.00 9/30/2024Robert I BlumCEOSell5,000$52.14$260,700.00 9/3/2024Fady Ibraham MalikEVPSell7,384$57.01$420,961.84 $100 Trillion “AI Metal” Found in American Ghost Town (Ad)Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.Click here to get the details on this virtual monopoly.9/3/2024Robert I BlumCEOSell5,000$57.03$285,150.00 8/12/2024B Lynne ParshallDirectorSell5,000$55.20$276,000.00 8/12/2024Robert I BlumCEOSell11,500$55.17$634,455.00 8/6/2024Fady Ibraham MalikEVPSell7,300$53.71$392,083.00 7/30/2024Robert I BlumCEOSell11,500$59.49$684,135.00 7/29/2024B Lynne ParshallDirectorSell5,000$59.84$299,200.00 7/23/2024Fady Ibraham MalikEVPSell7,300$57.02$416,246.00 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics' Insider Roster? The list of insiders at Cytokinetics includes Andrew Callos, B Lynne Parshall, Edward M Md Kaye, Fady Ibraham Malik, John T Henderson, Muna Bhanji, Robert Arthur Harrington, Robert I Blum, Robert Wong, and Wendall Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 3.40% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: Andrew Callos ($799,708.37), B Lynne Parshall ($1,388,150.00), Edward M Md Kaye ($116,715.60), Fady Ibraham Malik ($15,078,965.42), John T Henderson ($1,702,844.48), Muna Bhanji ($147,367.42), Robert Arthur Harrington ($108,411.03), Robert I Blum ($15,629,970.04), Robert Wong ($635,977.68), and Wendall Wierenga ($1,966,646.02). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 699,764 Cytokinetics shares in the last 24 months for a total of $37,574,756.06 sold. Cytokinetics Key ExecutivesMr. Robert I. Blum (Age 60)President and Chief Executive Officer Compensation: $1.33M8 recent tradesMr. Robert C. Wong (Age 56)VP & Chief Accounting Officer Compensation: $495.72kDr. Fady Ibraham Malik FACC (Age 60)M.D., Ph.D., Executive Vice President of Research & Development Compensation: $839.66kMr. Andrew M. Callos (Age 55)Executive VP & Chief Commercial Officer Compensation: $752.84k6 recent tradesDr. James A. Spudich Ph.D. (Age 82)Co-Founder & Member of Scientific Advisory Board Compensation: $21.94kMr. Jeff LotzVice President of Sales & OperationsMr. Matt YangVice President of Corporate Finance and Financial Planning & AnalysisMr. Steven M. Cook (Age 65)Senior Vice President of Global Supply Chain Operations & Technical Operations Ms. Kari K. Loeser J.D.VP & Chief Compliance OfficerMr. John O. Faurescu Esq.VP, Associate General Counsel & Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies ITCI Insider Transactions GMAB Insider Transactions MRNA Insider Transactions VTRS Insider Transactions BPMC Insider Transactions BBIO Insider Transactions VRNA Insider Transactions ROIV Insider Transactions ELAN Insider Transactions RVMD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:CYTK) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
